DOI: https://doi.org/10.14710/dimj.v5i1.21750

EFFECTS OF GARCINIA MANGOSTANA LINN PERICARP EXTRACT AND PHYSICAL EXERCISE ON ATHEROEMBOLIC HISTOPATHOLOGIC FEATURES KIDNEY IN WISTAR RATS WITH METABOLIC SYNDROME

*Evangga Yudha Perdana  -  Department of Medicine, Faculty of Medicine, Universitas Diponegoro, Jl. Prof. Sudarto, SH, Tembalang, Semarang, Indonesia 50275, Indonesia
Ika Pawitra Miranti  -  Department of Anatomical Pathology, Faculty of Medicine, Universitas Diponegoro, Jl. Prof. Sudarto, S.H., Tembalang, Semarang, Indonesia 50275, Indonesia
Open Access Copyright (c) 2024 Diponegoro International Medical Journal
Creative Commons License This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Citation Format:
Abstract

Background: Renal atheroembolism is an under-recognized cause of renal failure . Atheroembolism is caused by cholesterol crystals from ulcerated atherosclerotic plaques and is influenced by inflammation and endothelial dysfunction. The formation of complicated atherosclerotic lesions is a prerequisite for the development of cholesterol crystal emboli. Non-pharmacological therapeutic management (such as diet and physical exercise) is an important factor in preventing and reducing the risk of atherogenesis. Garcinia Mangostana Linn pericarp can inhibit the process of atherosclerosis through the reduction of free radicals and improvement of endothelial function Objective: To investigate the effect of Garcinia Mangostana Linn Pericarp administration along with Physical Exercise on the histopathologic features of renal atheroembolism in Wistar rats with metabolic syndrome. Methods: This study is a true experimental study with research subjects in the form of male Rattus norvegicus Wistar rats which were randomly divided into 3 groups. K (not given therapy), P1 (garcinia pericarp extract 800 mg / kg / day with physical exercise), and P2 (nanoemulsion 50 mg / kg / time of administration with physical exercise). Results: In the group treated with garcinia pericarp extract 800 mg/kg bw/day with physical exercise and the group with nanoemulsion 50 mg/kg bw/day with physical exercise, there were no fatty streaks, inflammation, and impaired myocyte coherence. There was 0-5% fibrous connective tissue, one layer of foam cell layer and myocyte-lipid, no cholesterol crystal embolism was found. Conclusion: The administration of Garcinia Mangostana Linn pericarp extract and/or nanoemulsion with physical exercise can have an effect on the histopathological picture of the kidneys of Wistar rats with metabolic syndrome. There was no difference in effect between the two treatments. However, it could not be compared with the group that was not given any treatment because it had died completely before the end of the study period.

Note: This article has supplementary file(s).

Fulltext View|Download |  Hasil Riset
EFFECTS OF GARCINIA MANGOSTANA LINN PERICARP EXTRACT AND PHYSICAL EXERCISE ON ATHEROEMBOLIC HISTOPATHOLOGIC FEATURES KIDNEY IN WISTAR RATS WITH METABOLIC SYNDROME
Subject atheroembolic, atherosclerosis, Garcinia Mangostana Linn Pericarp extract, nanoemulsion.
Type Hasil Riset
  Download (3MB)    Indexing metadata
Keywords: atheroembolic, atherosclerosis, Garcinia Mangostana Linn Pericarp extract, nanoemulsion.

Article Metrics:

Article Info
Section: Original Research Article
Language : EN
Recent articles
Effectiveness of Etanol Extract Bajakah Wood (Spatholobus sp.) on the Growth of Staphylococcus aureus ATCC 25923 The Relationship between Self-Esteem and Anxiety Levels in Final-year Medical Students The Relationship Between Social Media Addiction and Self-Esteem in Medical Students of Diponegoro University A review of single-handed coaxial phacoemulsification technique for cataract surgery More recent articles
  1. P. Jerome and Kassirer, “Atherombolic Renal Disiease,” N Engl J Med., vol. 314, no. 7, pp. 605–13, 2015
  2. H. Omar, A. Almaeen, S. Elghaffar, S. Ragab, T. El-Metwally, and E. Ahmed, “Atherosclerotic rat model after a high-fat, high-sucrose diet protective role of quercetin, o-coumaric, and berberie 40:76–84,” Anal Quant Cytopathol Histpathol, vol. 40, pp. 76–84, 2018
  3. R. Kones, “Primary prevention of coronary heart disease: Integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey,” Drug Des Devel Ther, vol. 5, pp. 325–80, 2011
  4. D. Oliver, O. John, P. Mouatt, S. Panchal, and L. Brown, “Rind from purple mangosteen (Garcinia mangostana) attenuates diet-induced physiological and metabolic changes in obese rats,” Nutrients, vol. 13, p. 319, 2021, doi: https://doi.org/10.3390/nu13020319
  5. M. Vaccarezza, C. Balla, and P. Rizzo, “Atherosclerosis as an inflammatory disease: doubts? no more,” IJC Hear. Vasc., vol. 19, pp. 1–2, 2018, doi: https://doi.org/10.1016/j.ijcha.2018.03.0032352-9067
  6. F. Scolari, P. Ravani, R. Gaggi, M. Santostefano, C. Rollino, and N. Stabellini, “The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors,” Circulation, vol. 116, no. 3, pp. 298–304, 2007
  7. X. Li, G. Bayliss, and S. Zhuang, “Cholesterol Crystal Embolism and Chronic Kidney Disease,” Int J Mol Sci, vol. 18, no. 6, p. 1120, 2017
  8. F. Scolari, R. Tardanico, R. Zani, A. Pola, B. Viola, and E. Movili, “Cholesterol crystal embolism: A recognizable cause of renal disease,” Am J Kidney Dis Off Natl Kidney Found, vol. 36, no. 6, pp. 1089–109
  9. J. Lie, “Cholesterol atheromatous embolism. The great masquerader revisited,” Pathol Annu, vol. Pt 2, pp. 17–50, 1992
  10. A. Ozkok, “Cholesterol-embolization syndrome : current perspectives,” Viscular Heal Risk Manag, vol. 15, pp. 209–20, 2019
  11. J. Davignon and P. Ganz, “Role of endothelial dysfunction in atherosclerosis,” Circulation, vol. 109, no. 23 Suppl 1, pp. III27-32, 2004
  12. A. Welz, A. Emberger-Klein, and K. Menrad, “Why people use herbal medicine: insights from a focus-group study in Germany,” BMC Complement Altern Med, vol. 18, no. 1, p. 92
  13. T.-W. Huang, B. Kota, V. Razmovski, and B. Roufogalis, “Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome,” Basic Clin Pharmacol Toxicol, vol. 96, no. 1, pp. 3–14
  14. H. S. Snyder, “A correlative study of atheroembolism in human beings and experimental animals,” Surgery, vol. 49, pp. 195–204, 1961
  15. A. Ismail and et al., “The role of Garcinia mangostana pericarp extract as antioxidant to inhibit atherosclerosis process in high-risk Framingham score patient.,” Hear. Sci J, vol. 2, no. 1, pp. 25–29, 2020
  16. S. Yurista, F. Safithri, D. Djunaedi, and D. Sargowo, “Effect of extract from pericarp of mangosteen (Garcinia mangostana Linn) as anti-inflammatory agent in rat models with atherosclerosis,” J Kardiol Indones, vol. 33, no. 1, pp. 4–9, 2012
  17. W. Xu and et al., “Development and in vivo evaluation of self-microemulsion as delivery system for α-mangostin, Kaohsiung,” J. Med. Sci.
  18. S. Grundy, J. Cleeman, S. Daniels, K. Donato, R. Eckel, and B. Franklin, “Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement,” Circulation, vol. 112, no. 17, pp. 2735–52
  19. B. Hanutami and A. Budiman, “Review Artikel: Penggunaan Teknologi Nano pada Formulasi Obat Herbal,” Farmaka, vol. 15, no. 2, pp. 29–41, 2017
  20. S. Yuliani, M. Hartini, Stephanie, B. Pudyastuti, and E. Istyastono, “Perbandingan Stabilitas Fisis Sediaan Nanoemulsi Minyak Biji Delima dengan Fase Minyak Long-Chain Triglyceride dan Medium-Chain Tryglyceride 2016;21(2):93–8.,” Tradit Med J, vol. 21, no. 2, pp. 93–8, 2016
  21. M. Anna and W. Andi, “Peroxisome Proliferator–Activated Receptors and The Metabolic Syndrome,” Indones Biomed J, vol. 1, no. 1, pp. 4–31, 2009
  22. U. Septiana, O. Pramudita, I. Retfiliastuti, and L. Sholikhah, “Analisis Potensi Senyawa Mangostin dalam Ekstrak Kulit Manggis (Garcinia mangostana L.) sebagai Agen Antiinflamasi,” J Jendela Inov Drh., vol. 6, no. 2, pp. 72–86, 2023
  23. I. Japardi, “Patofisiologi Stroke Infark Akibat Tromboemboli,” 2002, [Online]. Available: https://api.semanticscholar.org/CorpusID:73028578.%0A

Last update:

No citation recorded.

Last update:

No citation recorded.